U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020156) titled 'A First-in-Human Phase I Trial of OX118 in Healthy Volunteers' on April 02.
Brief Summary: This is a first-in-human, phase 1 study of OX118 in healthy volunteers, designed to investigate the safety and tolerability of OX118, as well as its pharmacokinetics (the drug's concentration in the blood and excretion from the body).
The study will include a total of 32 participants: healthy men and women aged 18-60 years with a body mass index (BMI) between >=18.5 and ≤30.0.The study is divided into five cohorts where OX118 will be given as a single dose intravenously (into the blood).
The study consists of 7 clinic visits taking pla...